AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
ARTERIAL OCCLUSIONS AS A PRESENTING FEATURE OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors: ROLSTON DDK RUBIN S TOPOLSKY D STYLER M CRILLEY P
Citation: Ddk. Rolston et al., ARTERIAL OCCLUSIONS AS A PRESENTING FEATURE OF ACUTE PROMYELOCYTIC LEUKEMIA, American journal of clinical oncology, 21(5), 1998, pp. 436-437
EFFECT OF CLINICAL OUTCOMES DATA ON INTENSIVE-CARE UNIT UTILIZATION BY BONE-MARROW TRANSPLANT PATIENTS
Authors: PAZ HL GARLAND A WEINAR M CRILLEY P BRODSKY I
Citation: Hl. Paz et al., EFFECT OF CLINICAL OUTCOMES DATA ON INTENSIVE-CARE UNIT UTILIZATION BY BONE-MARROW TRANSPLANT PATIENTS, Critical care medicine, 26(1), 1998, pp. 66-70
SUSTAINED ENGRAFTMENT IN MATCHED UNRELATED DONOR TRANSPLANT (MUD) RECIPIENTS WITH HEMATOLOGIC MALIGNANCIES WITH A BUSULFAN-CYCLOPHOSPHAMIDEMARROW PREPARATIVE REGIMEN
Authors: CRILLEY P TOPOLSKY DL STYLER MJ BRODSKY I
Citation: P. Crilley et al., SUSTAINED ENGRAFTMENT IN MATCHED UNRELATED DONOR TRANSPLANT (MUD) RECIPIENTS WITH HEMATOLOGIC MALIGNANCIES WITH A BUSULFAN-CYCLOPHOSPHAMIDEMARROW PREPARATIVE REGIMEN, Blood, 90(10), 1997, pp. 4524-4524
AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION
Authors: LINKER CA RIES CA DAMON LE RUGO HS WOLF JL TOPOLSKY D CRILLEY P BRODSKY I RUBIN A CASE D ZAMKOFF K
Citation: Ca. Linker et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION, Blood, 90(10), 1997, pp. 493-493
LOW INCIDENCE OF FUNGAL-INFECTIONS IN PATIENTS UNDERGOING UNRELATED DONOR BONE-MARROW TRANSPLANTS FOLLOWED BY GM-CSF
Authors: CRILLEY P TOPOLSKY D MARKS DI STYLER M SABOL P BRODSKY I
Citation: P. Crilley et al., LOW INCIDENCE OF FUNGAL-INFECTIONS IN PATIENTS UNDERGOING UNRELATED DONOR BONE-MARROW TRANSPLANTS FOLLOWED BY GM-CSF, Experimental hematology, 24(9), 1996, pp. 633-633
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER PREPARATION WITH BUCY2
Authors: COPELAN EA BIGGS JC SZER J CRILLEY P ATKINSON K AVALOS B TOPOLSKY D PENZA SL ELDER PJ BULOVA SL BRODSKY I
Citation: Ea. Copelan et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER PREPARATION WITH BUCY2, Experimental hematology, 24(9), 1996, pp. 670-670
HEPATIC-DYSFUNCTION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE MYELOABLATION - A RETROSPECTIVE, MULTICENTER ANALYSIS
Authors: STYLER MJ CRILLEY P BIGGS J MOUL J COPELAN E TOPOLSKY D AVALOS B PENZA S SABOL P DOWNS K SZER J BRODSKY I MARKS DI
Citation: Mj. Styler et al., HEPATIC-DYSFUNCTION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE MYELOABLATION - A RETROSPECTIVE, MULTICENTER ANALYSIS, Bone marrow transplantation, 18(1), 1996, pp. 171-176
UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION USING HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY) FOR THE PREPARATIVE REGIMEN
Authors: SAHEBI F COPELAN E CRILLEY P BOLWELL B AVALOS B KLEIN J TERRITO M GAJEWSKI J
Citation: F. Sahebi et al., UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION USING HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY) FOR THE PREPARATIVE REGIMEN, Bone marrow transplantation, 17(5), 1996, pp. 685-689
UNRELATED DONOR BONE-MARROW TRANSPLANTATION WITHOUT T-CELL DEPLETION USING A CHEMOTHERAPY ONLY CONDITIONING REGIMEN - LOW INCIDENCE OF FAILED ENGRAFTMENT AND SEVERE ACUTE GVHD
Authors: TOPOLSKY D CRILLEY P STYLER MJ BULOVA S BRODSKY I MARKS DI
Citation: D. Topolsky et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION WITHOUT T-CELL DEPLETION USING A CHEMOTHERAPY ONLY CONDITIONING REGIMEN - LOW INCIDENCE OF FAILED ENGRAFTMENT AND SEVERE ACUTE GVHD, Bone marrow transplantation, 17(4), 1996, pp. 549-554
SEXUAL DYSFUNCTION PRIOR TO HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION
Authors: MARKS DI CRILLEY P NEZU CM NEZU AM
Citation: Di. Marks et al., SEXUAL DYSFUNCTION PRIOR TO HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 17(4), 1996, pp. 595-599
LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS FOR VENOOCCLUSIVE DISEASE INUNRELATED MARROW TRANSPLANT RECIPIENTS
Authors: STYLER M CRILLEY P TOPOLSKY D RUBIN S SABOL P KING R BRODSKY I
Citation: M. Styler et al., LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS FOR VENOOCCLUSIVE DISEASE INUNRELATED MARROW TRANSPLANT RECIPIENTS, Blood, 88(10), 1996, pp. 3765-3765
THE USE OF G-CSF AFTER PERIPHERAL STEM-CELL (PBSC) TRANSPLANT - BEGINNING AT DIFFERENT INTERVALS POST INFUSION
Authors: TOPOLSKY D KING R MULLANEY R STYLER M CRILLEY P SABOL P BRODSKY L
Citation: D. Topolsky et al., THE USE OF G-CSF AFTER PERIPHERAL STEM-CELL (PBSC) TRANSPLANT - BEGINNING AT DIFFERENT INTERVALS POST INFUSION, Blood, 88(10), 1996, pp. 3766-3766
EXTRAMEDULLARY TOXICITY OF A CONDITIONING REGIMEN CONTAINING BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE IN 84 PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: CRILLEY P TOPOLSKY D STYLER MJ BERNSTEIN E RESNICK K MULLANEY R BULOVA S BRODSKY I MARKS DI
Citation: P. Crilley et al., EXTRAMEDULLARY TOXICITY OF A CONDITIONING REGIMEN CONTAINING BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE IN 84 PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(3), 1995, pp. 361-365
TRANSLOCATION-11-14 IN NEWLY-DIAGNOSED CHRONIC MYELOGENOUS LEUKEMIA
Authors: MAGDALINSKI A DRWINGA H CRILLEY P LASOTA J BRODSKY I CROCE CM NOWELL PC MARKS DI
Citation: A. Magdalinski et al., TRANSLOCATION-11-14 IN NEWLY-DIAGNOSED CHRONIC MYELOGENOUS LEUKEMIA, Cancer genetics and cytogenetics, 81(1), 1995, pp. 24-27
PERIPHERAL-BLOOD STEM-CELL TRANSPLANT IN BREAST-CANCER
Authors: CRILLEY P GOLDSTEIN LJ
Citation: P. Crilley et Lj. Goldstein, PERIPHERAL-BLOOD STEM-CELL TRANSPLANT IN BREAST-CANCER, Seminars in oncology, 22(3), 1995, pp. 238-249
AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION
Authors: LINKER CA RIES CA DAMON LE RUGO HS TOPOLSKY D CRILLEY P BRODSKY I RUBIN A CASE D
Citation: Ca. Linker et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION, Blood, 86(10), 1995, pp. 384-384
EFFECT OF INFLUENZA VACCINE POST-ALLOGENEIC BONE-MARROW TRANSPLANT
Authors: TOPOLSKY D BLUMBERG E CRILLEY P STYLER M HAYDEN F CHURCHILL K MORRIS M BRODSKY I
Citation: D. Topolsky et al., EFFECT OF INFLUENZA VACCINE POST-ALLOGENEIC BONE-MARROW TRANSPLANT, Blood, 86(10), 1995, pp. 860-860
OCULAR GRAFT-VERSUS-HOST DISEASE
Authors: HEFFLER KF GROSSMAN H MARKS D TOPOLSKY D STYLER M MOUL J CRILLEY P BRODSKY I
Citation: Kf. Heffler et al., OCULAR GRAFT-VERSUS-HOST DISEASE, Blood, 86(10), 1995, pp. 3784-3784
UNRELATED DONOR BONE-MARROW TRANSPLANTATION IN OLDER PATIENTS
Authors: MARKS DI TOPOLSKY D CRILLEY P STYLER MJ BULOVA S BRODSKY I
Citation: Di. Marks et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION IN OLDER PATIENTS, Blood, 86(10), 1995, pp. 3813-3813
BUCY3 CONDITIONING FOR UNRELATED DONOR TRANSPLANTS FOR HEMATOLOGIC MALIGNANCIES
Authors: MARKS D CRILLEY P STYLER M TOPOLSKY D MANALO Y BRODSKY I
Citation: D. Marks et al., BUCY3 CONDITIONING FOR UNRELATED DONOR TRANSPLANTS FOR HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000336-10000336
CHARACTERIZATION OF HUMAN BONE MARROW-DERIVED CLOSED CIRCULAR DNA CLONES
Authors: LOU ZW KASTURY K CRILLEY P LASOTA J DRUCK T CROCE CM HUEBNER K
Citation: Zw. Lou et al., CHARACTERIZATION OF HUMAN BONE MARROW-DERIVED CLOSED CIRCULAR DNA CLONES, Genes, chromosomes & cancer, 7(1), 1993, pp. 15-27
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE
Authors: BRODSKY I BIGGS JC SZER J CRILLEY P ATKINSON K DOWNS K DODDS A CONCANNON AJ AVALOS BR TUTSCHKA P KAPOOR N TOPOLSKY D BULOVA SI COPELAN EA
Citation: I. Brodsky et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE, Seminars in oncology, 20(4), 1993, pp. 27-31
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA, ACUTE LYMPHOCYTIC-LEUKEMIA, AND MULTIPLE-MYELOMA FOLLOWING PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2)
Authors: COPELAN EA BIGGS JC SZER J THOMPSON JM CRILLEY P BRODSKY I KLEIN JL KAPOOR N HARMAN GS AVALOS BR
Citation: Ea. Copelan et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA, ACUTE LYMPHOCYTIC-LEUKEMIA, AND MULTIPLE-MYELOMA FOLLOWING PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2), Seminars in oncology, 20(4), 1993, pp. 33-38
COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES
Authors: CRILLEY P LAZARUS H TOPOLSKY D CIOBANU N CREGER RJ FOX RM BULOVA SI SHINA DC GUCALP R COOPER BW SOEGIARSO W STYLER M BRODSKY I
Citation: P. Crilley et al., COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES, Seminars in oncology, 20(4), 1993, pp. 50-54
PREPARATIVE REGIMENS IN BONE-MARROW TRANSPLANTATION - A PANEL DISCUSSION
Authors: BRODSKY I APPELBAUM FR COPELAN EA CRILLEY P GROCHOW LB LINKER CA SANTOS GW SARAL R
Citation: I. Brodsky et al., PREPARATIVE REGIMENS IN BONE-MARROW TRANSPLANTATION - A PANEL DISCUSSION, Seminars in oncology, 20(4), 1993, pp. 65-67
Risultati: 1-25 | 26-30